back to main menu
Biotechnology and Medical Technology Program Trends by Emerging Tech Category, by Buyers/Programs, by Use Cases and Applications, by Geographic Location, and by Companies (including Underserved)
Table of Contents
Biotechnology and medical technology serve as pillars of progress, critical for enhancing healthcare, driving economic growth, and ensuring national well-being. U.S. federal government has made strategic investments through various policies including Bioeconomy Blueprint, NIH BRAIN Initiative, and Precision Medicine etc., demonstrate its commitment to fortifying these vital sectors.
This report and accompanying datasets and dashboard provide deep insights into the Microelectronics market, which use cases are being funded, who is investing in them, which companies are winning, and which regions are emerging as the new hotbeds of innovation.
Want access? Contact us
Highlights from our ongoing analysis
  • The U.S. federal government's current investments and collaborations bolster not only national defense capabilities but also the growth and competitiveness of the biotechnology market, fostering advancements with broader societal implications. Such as HHS allocated $40 million to bolster biomanufacturing for pharmaceutical ingredients and pandemic response. Additionally, the DOD is launching a $270 million Tri-Service Biotechnology program over five years to expedite research into bio-based materials for defense supply chains. Furthermore, the DoD is investing $1 billion in bioindustrial domestic manufacturing infrastructure over five years, fostering a robust and accessible domestic bioindustrial base for U.S. innovators.
  • The objective of this report is to cover the federal R&D landscape by examining investments made in Biotechnology and Medical Technology through SBIR/STTR, Grants, and Other Transactions Awards during FY2018-FY2022.
  • Some high-level insights include:
    • Over $3.13T spent on Biotechnology & Medical Technology R&D by the U.S. federal government and it has seen 62% growth during FY2018-FY2022
    • 99% of Biotechnology & Medical Technology-related federal R&D awards were made through grants worth $3.11T during FY18-FY22. During the same time period, $6B worth of SBIR/STTR awards were awarded for Biotechnology & Medical Technology-related R&D awards. Majority of the investments were made to cope up with the COVID-19 pandemic.
    • Use Cases – Market verticals where technology adoption is highest include Healthcare and Medicine, Agriculture, Environmental Production, and Energy and Biofuels etc. Examples of high frequency use cases being invested include Drug Discovery, Precision Agriculture, Environmental Remediation, Biogas Production, Animal Breeding and Organ Transplantation, etc.
    • Agencies – HHS has awarded more than 92% of the R&D awards. Within HHS, Centers for Medicare and Medicaid Services and National Institutes of Health made the most R&D investments. Other prominent agencies include DOA, DOD, DHS which comprises approximately $148B worth of biotechnology & medical technology awards.
    • 39K+ Suppliers and Research Institutions were awarded Biotechnology and Medical Technology R&D awards during FY18-FY22; Only 14% of awardees were underserved. SBIR/STTR program has utilized the highest proportion of underserved suppliers with 39%, OTAs utilized 15% underserved suppliers whereas grants had the lowest share of underserved suppliers at 13%
    • Emerging Regional Innovation Clusters – Various innovation clusters are emerging in regions such as Sacramento-Roseville-Folsom, CA, Boston-Cambridge-Newton, MA-NH and Albany-Schenectady-Troy, NY etc. These R&D innovation “hotbeds” have attracted the highest proportion of R&D investments.
Table of Contents
  1. Report Introduction
    1. Report Introduction
    2. Introduction and Methodology
    3. R&D Data Sets Analyzed
  2. Defining Critical and Emerging Technologies
    1. Critical Technologies Defined by Various Agencies and Their Policies
    2. Consolidated Critical Technologies based on PSF’s AI-MI Market Ontology Match
  3. Biotechnology Market Overview and Industry Trends
    1. Biotechnology Ecosystem Mapping
    2. Market Breakdown by Technology
    3. Market Breakdown by End-Use Industries
    4. Use-Cases and Technologies in Different Market Verticals Funded by Federal Government
  4. R&D Award Trend Analysis
    1. R&D Awards Growth Trend by Year and Funding Sources
    2. R&D Award Breakdown by Funding Sources
  5. Federal Demand Analysis and Portfolio of Agencies & Programs
    1. Federal Agencies Breakdown by R&D Investments and Funding Sources
    2. Utilization of Different R&D Contracting Channels (Funding Sources) Across Federal Agencies
    3. Example List of Program Offices Involved in Biotechnology
    4. Example List of Program Offices and R&D Awards
  6. Portfolio of Companies Winning R&D Awards
    1. Suppliers Involvement Based on Underserved Status
    2. Suppliers Trend Analysis by R&D Awards Across Different Funding Sources
    3. Suppliers Breakdown by Socioeconomic Designations
    4. Comparative Analysis of Underserved Suppliers Across Different Funding Sources (i.e., SBIR/STTR, Grants and OTAs)
    5. Suppliers Breakdown by Number of R&D Awards and Funding Sources
    6. Example List of R&D Funded Suppliers with Capabilities and Experience Data
  7. Other Ecosystem Participants
    1. Breakdown of Venture Capital Firms, Accelerators, Investment Partners, and Other Financing Institutions
    2. Illustrative List of Research Institutions/ Facilities and Universities with Sample Profile
  8. Regional Innovation Clusters Analysis
    1. Top 50 Regional Innovation Clusters by Federal Funding Sources based on Absolute and Per Capita Amount
    2. Top 50 Regional Innovation Clusters by All R&D Funding
Want access? Contact us
What Others are Saying About Our Analysis
This is a terrific report. We're going to share internally. Is it okay to share external to the DOD. There are more than a handful of companies that would find this useful.
Director at Defense Innovation Unit
This is some of the best work I’ve ever seen using taxonomies and unstructured data! Imagine, applying this same analysis to millions all investments by region and people.
Executive Director, University of Chicago Center for Impact Sciences
This is fantastic data! We certainly would like a briefing.
SVP of Microelectronics and Advanced Technologies, Large OTA Manager
Detailed Preview Report
Report includes market data points, ranging from trend analyses to market estimates & forecasts.

Thank you for your interest. Please complete form below and we will be in touch.

Complete Form Below to Download Report.